• Home
  • Company
    • About Us
    • Team
    • Work With Us / FCOI
  • Products
  • Diseases
  • News
  • Contact Us
Close
  • Home
  • Company
    • About Us
    • Team
    • Work With Us / FCOI
  • Products
  • Diseases
  • News
  • Contact Us
HomeNewsCrossLife Awarded NIH SBIR Grant for...

CrossLife Awarded NIH SBIR Grant for Chikungunya Point-of-Care Diagnostic

CrossLife Awarded NIH SBIR Grant for Chikungunya Point-of-Care Diagnostic

July 2016 |

CrossLife has recently been awarded a Phase 1 Small Business Innovative Research (SBIR) grant from NIH/NIAID for A Rapid Paper Strip Nucleic Acid Test for the Detection of Chikungunya at the Point of Care

 

https://projectreporter.nih.gov/project_info_description.cfm?aid=9198877&icde=31581540&ddparam=&ddvalue=&ddsub=&cr=2&csb=default&cs=ASC

 

 

 

Recent News
  • CrossLife Tech’s IsoTARA COVID-19 Colorimetric Assay has been developed and submitted for EUA approval
  • CrossLife Tech’s Molecular Test for the Novel Coronavirus, CLT™ SARS-CoV-2 qRT-PCR, Has Developed.
  • CrossLife Awarded NIH SBIR II Grant for HIV Point-of-Care Diagnostic
  • Serve on Special Emphasis Review Panel
  • CrossLife on the News for NCATS Feature Story
Archives
  • June 2020
  • October 2018
  • March 2017
  • February 2017
  • January 2017
  • October 2016
  • July 2016
  • June 2016
  • May 2016
  • March 2016
  • January 2016
  • December 2015
  • November 2015
  • June 2015
CrossLife Technologies © 2019. All Rights Reserved